180
Participants
Start Date
June 10, 2020
Primary Completion Date
April 22, 2021
Study Completion Date
June 22, 2021
Anti- SARS-CoV-2 Plasma
SARS-CoV-2 convalescent plasma (1 unit; \~200-250 mL collected by pheresis from a volunteer who recovered from COVID-19 disease and has SARS-CoV-2 antibody titers ≥ 1:320
SARS-CoV-2 non-immune Plasma
Normal human plasma collected prior to December 2019
Vassar Brothers Medical Center, Poughkeepsie
University of Rochester, Rochester
MedStar Georgetown University Hospital, Washington D.C.
The Johns Hopkins University, Baltimore
Anne Arundel Medical Center, Annapolis
University of Miami, Coral Gables
University of Miami Clinical Translational Research Site, Miami
University of Alabama at Birmingham, Birmingham
University of Cincinnati Medical Center, Cincinnati
Wayne State University, Detroit
NorthShore University HealthSystem, Evanston
Baylor College of Medicine, Houston
University of Texas Health Science Center at Houston, Houston
The University of Utah, Salt Lake City
Center for American Indian Health - Whiteriver Office, Whiteriver
University of New Mexico Health Sciences Center, Albuquerque
Center for American Indian Health - Gallup Office, Gallup
Center for American Indian Health - Shiprock Office, Shiprock
University of California, Los Angeles, Los Angeles
University of California, San Diego, La Jolla
University of California, Irvine Health, Orange
Western Connecticut Health Network, Danbury Hospital, Danbury
Western Connecticut Health Netowrk, Norwalk Hospital, Norwalk
University of Massachusetts Worcester, Worcester
Lifespan/BrownUniversity (Rhode Island Hospital), Providence
Johns Hopkins University
OTHER